GBIO: Generation Bio Co Company Profile & Statistics

About

Generation Bio Co. is a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases. The company is developing distinct and complementary platforms a potent, highly selective cell-targeted lipid nanoparticle delivery system and a novel immune-quiet DNA cargo produced by a scalable capsid-free manufacturing process which uses proprietary cell-free rapid enzymatic synthesis. Generation Bio Co. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Geoff McDonough

Headquarters

301 BINNEY STREET
CAMBRIDGE, MA 02142, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

174

Generation Bio Co Statistics

Valuation Measures

Market Capitalization²

68.46M

Enterprise Value

46.80M

Enterprise Value/EBITDA(ttm)

-0.31

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.17

Price to Book(mrq)

0.74

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-782.86%

Profit Margin(ttm)

-940.29%

Return on Equity(ttm)

-104.85%

Return on Invested Capital(ttm)

-106.16%

Return on Assets(ttm)

-49.54%

Income Statement

Revenue(ttm)

18.58M

Revenue Per Share(ttm)

0.28

Gross Profit(ttm)

18.58M

EBITDA(ttm)³

-152.17M

Net Income Available to Common(ttm)

-145.47M

Diluted EPS(ttm)

-2.19

Share Statistics

Beta (5Y Monthly)

2.66

52-Week Change

-32.12%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

66.79M

Dividend Yield

0.00%

Float⁴

52.70M

% Held by Insiders

21.10%

% Held by Institutions

95.22%

Balance Sheet

Total Cash(mrq)

184.77M

Total Cash Per Share(mrq)

2.77

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.34%

Quick Ratio(mrq)

6.34%

Book Value Per Share(mrq)

1.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.09

Free Cash Flow(ytd)

-74.65M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

GBIO

Generation Bio Co

Generation Bio Co Profile